Welcome to our dedicated page for Cvs Health news (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on Cvs Health stock.
News about CVS Health Corporation (NYSE: CVS) covers developments across its roles in retail pharmacy, pharmacy benefit management, health insurance and health care delivery. Company press releases and related disclosures highlight how CVS Health communicates financial performance, strategic priorities, governance updates and community initiatives to investors, customers and the public.
Investors following CVS stock can find news on quarterly and full-year earnings announcements, financial guidance updates and Investor Day presentations. For example, CVS Health has issued press releases discussing results for specific quarters, updating full-year financial guidance and providing outlooks for future years, including projections for revenues, operating income, adjusted operating income, GAAP diluted earnings (loss) per share and adjusted EPS. These communications often appear in conjunction with Form 8-K filings that furnish the underlying press releases.
Corporate governance and leadership changes are another recurring news theme. CVS Health has announced Board decisions such as appointing its President and Chief Executive Officer, J. David Joyner, to the additional role of Chair of the Board, and it has used both press releases and Form 8-K filings to describe these actions and related Board structures.
Operational and community-focused news items describe how CVS Health engages with public health and local organizations. Examples include offering the measles-mumps-rubella (MMR) vaccine at select CVS Pharmacy and MinuteClinic locations in South Carolina during a measles outbreak, and the CVS Health Foundation’s grants to the American Diabetes Association to expand a maternal diabetes program in New York City. Other stories highlight investments in affordable housing projects and the company’s reported economic impact across U.S. states.
Visitors to this news page can review these types of announcements to understand how CVS Health presents its strategy, financial outlook, health services, community partnerships and responses to health challenges over time.
CVS Health has implemented time delay safe technology in all 106 CVS Pharmacy locations across Colorado, Utah, Montana, Idaho, and Wyoming to combat organized retail crime. This initiative aims to prevent pharmacy robberies and the diversion of controlled substances, including opioids. The technology has previously demonstrated significant success, achieving a 70% reduction in robberies in Indianapolis and a 50% decline nationwide. CVS remains committed to supporting law enforcement in fighting organized retail crime, ensuring the safety of its customers and employees.
Biofourmis, a leader in digital medicine, has raised an additional $320M in Series D funding, with Intel Capital joining the round. This funding aims to enhance their virtual care offerings and digital therapeutics. Notably, the company appointed Trevor Fetter and Sachin H. Jain to its Board, enhancing leadership with extensive healthcare experience. Biofourmis is positioned for growth amid a general downturn in digital health funding, indicating strong market validation and potential for innovative care solutions.
Aetna, a CVS Health company, is launching individual insurance plans in California's ACA exchange, aiming to expand healthcare access to more residents. This initiative, effective January 1, 2023, will provide affordable care through a network of primary care doctors and mental health providers, along with telehealth options. The plans include comprehensive services such as pediatric care, hospitalization, and mental health services, ensuring quality care and access to over 1,100 MinuteClinic locations nationwide.
CVS Health Corporation reported second-quarter results for the period ending June 30, 2022, with total revenues of $80.6 billion, an 11% increase year-over-year. GAAP diluted EPS rose to $2.23, while adjusted EPS slightly decreased to $2.40. Operating income achieved $4.6 billion, supported by a $225 million gain from the sale of PayFlex. Full-year guidance for 2022 includes a raised GAAP EPS range of $7.23 to $7.43 and cash flow from operations guidance of $12.5 to $13.5 billion. The company remains focused on expanding health services amidst economic challenges.
CVS Health will host a conference call for analysts and investors on August 3, 2022, at 8:00 a.m. ET to discuss its second quarter 2022 financial results. The call will be accessible via an audio webcast on the CVS Health Investor Relations website, where it will be archived for one year. CVS Health is a leading health solutions company dedicated to improving community health through its extensive services and workforce, including over 40,000 healthcare professionals.
The 2022 Health Care Insights Study by CVS Health reveals a shift in U.S. consumer attitudes towards healthcare post-COVID-19. Conducted with 1,000 consumers and 400 providers, the study indicates that over 81% of consumers value their provider's awareness of life satisfaction. A significant 83% emphasize integrated care coordination. Virtual visits have become crucial, with 92% of participants considering convenience key to provider selection. Trust in healthcare providers has strengthened, with 44% of consumers expressing greater appreciation than pre-pandemic.
CVS Health has appointed Tilak Mandadi as Executive Vice President and Chief Data, Digital and Technology Officer, effective July 25. He will oversee the company's digital strategy and aim to enhance consumer-focused experiences. Mandadi, previously with MGM Resorts International, brings extensive experience from Disney and American Express. CVS serves over 44 million unique digital customers and aims to integrate digital solutions to improve the health care experience. This move underscores CVS's commitment to utilizing technology for growth and customer engagement.
CVS Health (NYSE: CVS) has approved a quarterly dividend of $0.55 per share on its Common Stock. The payment is scheduled for August 1, 2022, to shareholders on record as of July 22, 2022. CVS Health, a leading health solutions company, operates with a workforce of over 300,000 employees, including 40,000 healthcare professionals. The company focuses on enhancing access to healthcare and lowering costs for communities across America.
Aetna Better Health of Kansas, a CVS Health company, announced a donation of $125,000 to support community health initiatives across Kansas. This funding will assist five local organizations addressing critical health and social care needs, including mental health and housing. Since 2021, Aetna has contributed over $330,000 to various community organizations in the state. The aim of these donations is to enhance access to care and improve well-being for underserved populations in Kansas.
CVS Health (NYSE: CVS) announced that Shawn Guertin, Executive Vice President and Chief Financial Officer, will participate in a fireside chat with investors at the Goldman Sachs Global Healthcare Conference on June 15, 2022, at approximately 8:00 am Pacific Time. An audio webcast of this event will be available on the CVS Health Investor Relations website and archived for one year. CVS Health provides diverse health solutions, improving community health across America through a strong workforce and various services.